newsfilter
← Latest News
GlobeNewswire·

Evaxion announce 2027 financial calendar

  • Evaxion A/S (NASDAQ: EVAX) announced its financial calendar for 2027.
  • March 4, 2027: Scheduled for a business update and full year 2026 financial results.
  • April 29, 2027: Annual General Meeting planned.
  • May 4, 2027: Business update and first quarter 2027 financial results scheduled.
  • August 19, 2027: Business update and second quarter 2027 financial results scheduled.
  • November 18, 2027: Business update and third quarter 2027 financial results scheduled.
  • Additional event details, including conference call access, are available on the company website.
  • Mads Kronborg serves as Vice President, Investor Relations & Communication.
  • Evaxion operates as a clinical-stage TechBio company utilizing its AI-Immunology™ platform.
  • The company's pipeline includes personalized and off-the-shelf cancer vaccines plus prophylactic vaccines for infectious diseases.
  • The announcement includes forward-looking statements subject to risks such as capital needs, development success, regulatory hurdles, and market acceptance.
Company
Evaxion
Keywords
Nasdaq:EVAX, Evaxion, Financial calendar